Acupuncture for allergic rhinitis: a systematic review and meta analysis
Autor: | Xiao-peng Ma, Cui-hong Zhang, Qin-feng Huang, Dan Zhang, Ling-xiang Wu, Jue Hong, Jie Liu, Jun Ji |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Blinding Chinese patent medicine business.industry Electroacupuncture medicine.medical_treatment Cochrane Library 030226 pharmacology & pharmacy law.invention 03 medical and health sciences 0302 clinical medicine Systematic review 030228 respiratory system Complementary and alternative medicine Randomized controlled trial law Meta-analysis Physical therapy Acupuncture Medicine business |
Zdroj: | Journal of Acupuncture and Tuina Science. 14:426-437 |
ISSN: | 1993-0399 1672-3597 |
DOI: | 10.1007/s11726-016-0962-y |
Popis: | To analyze and review the clinical efficacy of acupuncture (including electroacupuncture) alone for allergic rhinitis (AR) and to compare its efficacy with antihistamines and Chinese patent medicine Bi Yan Kang Tablet. The search strategy, inclusion and exclusion criteria were made according to the principle of evidence-based medicine. We performed a systematic search on China National Knowledge Infrastructure (CNKI), Wanfang Academic Journal Full-text Database (Wanfang), Chongqing VIP Database (CQVIP), Chinese Biomedical Literature Database (CBM), PubMed, Excerpta Medica Database (EMBASE), Web of Science, Cochrane Library, and Cochrane Central Register of Controlled Trials (CENTRAL) for randomized controlled trials (RCTs) of acupuncture for allergic rhinitis between January 1990 and December 2015. The quality was evaluated by Cochrane Handbook for Systematic Reviews of Interventions Version 5.1, and the meta-analysis was conducted by RevMan 5.3 version. Twenty eligible RCTs were included into the meta-analysis after selection. Compared with antihistamines, the meta-analysis showed RR=1.24>1, 95%CI[1.15, 1.33], P 0, 95%CI[–10.84, 13.75], P = 0.82, indicating that there was no statistical difference between acupuncture and antihistamines in regulating immunoglobulin E (IgE) in AR patients. Compared with Bi Yan Kang Tablet, the meta-analysis has shown RR = 1.50>1, 95%CI[1.30, 1.73], P |
Databáze: | OpenAIRE |
Externí odkaz: |